Egle Therapeutics logo

Egle Therapeutics

Modulating T-regulatory cells to balance immunity

45 employees · est. 2020 · Paris, France

VS
Mozart Therapeutics, Inc. logo

Mozart Therapeutics, Inc.

Orchestrating the Immune System

36 employees · est. 2020 · Seattle, United States

Side-by-Side Comparison

Egle Therapeutics Mozart Therapeutics, Inc.
Founded
2020 2020
Headquarters
Paris, France Seattle, United States
Employees
45 36
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology
Funding Stage
Grant Series A
Total Funding
$49.30M $80.00M
Funding Rounds
2 2
Services
developing breakthrough therapies designed to modulate regulatory T cells for the treatment of cancer and autoimmune diseases Development of CD8 Treg modulators, Research and Development in immunology, Clinical Trials for new therapies, Biologics for autoimmune treatment
Target Customers
patients with cancer and autoimmune diseases Patients with autoimmune diseases, Healthcare providers, Medical researchers, Pharmaceutical investors
Taxonomy
Immunomodulation, T-regulatory Cells, Immunotherapy, Oncology, Autoimmune Diseases, Immune Suppressor, Regulatory T-cells, Paris, Emerging, Cancer Treatment, Immune System, Therapeutic Development Biopharmaceuticals, Clinical-stage, Autoimmune Disease, Disease-modifying Therapies, Immune System Modulation, CD8 Treg Modulators, Immune Homeostasis, Regulatory T Cells, Autoimmune Disorders, Inflammatory Diseases, Immune Surveillance Dysregulation, Immune Balance Restoration
Website
egle-tx.com mozart-tx.com
Egle Therapeutics logo

About Egle Therapeutics

Egle Therapeutics is a biotechnology startup based in France, founded in 2020. The company focuses on modulating T-regulatory cells (Tregs) to balance immunity, employing a unique concept that involves starving Tregs while specifically targeting the most immunosuppressive ones. Egle Therapeutics rec...

Mozart Therapeutics, Inc. logo

About Mozart Therapeutics, Inc.

Mozart Therapeutics, Inc., founded in 2020, is a promising player in the biotechnology industry, based in the United States. With the compelling slogan, "Orchestrating the Immune System," the company is strategically positioned as a clinical-stage biopharmaceutical firm dedicated to developing pione...

We will tell you when either one moves

BounceWatch watches Egle Therapeutics and Mozart Therapeutics, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Egle Therapeutics and Mozart Therapeutics, I... — by email.

Frequently Asked Questions

Egle Therapeutics — Modulating T-regulatory cells to balance immunity. Mozart Therapeutics, Inc. — Orchestrating the Immune System. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Egle Therapeutics has raised $49.30M while Mozart Therapeutics, Inc. has raised $80.00M.
Egle Therapeutics and Mozart Therapeutics, Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Egle Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Egle Therapeutics on 11 Jun 2025, and Mozart Therapeutics, Inc. on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes